Low-dose lithium aspartate did not improve fatigue and cognitive dysfunction symptoms in long COVID. A small dose-finding study suggested higher doses might be effective, but a new trial is needed.
BUFFALO, N.Y. — A small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of ...
A pilot clinical trial has found that low-dose lithium tablets might help slow verbal decline among seniors with mild ...
Dear Dr. Roach: Would it be risky to take a low dose (20 mg) of over-the-counter lithium orotate to treat cognitive decline? The recent study in the journal Nature recommended waiting for further ...
A small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of long COVID; ...
Lithium—a decades-old treatment for bipolar disorder—may hold potential neuroprotective benefits beyond mood stabilization. An exploratory clinical trial from the University of Pittsburgh suggests ...
DEAR DR. ROACH: Would it be risky to take a low dose (20 mg) of over-the-counter lithium orotate to treat cognitive decline? The recent study in the journal Nature recommended waiting for further ...
A small clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of long COVID. A small University at ...
Lithium—a decades-old treatment for bipolar disorder—may hold potential neuroprotective benefits beyond mood stabilization. An exploratory clinical trial from the University of Pittsburgh suggests ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results